A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Bristol-Myers Squibb
University Hospital, Essen
Neonc Technologies, Inc.
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Maastricht University Medical Center
Vyriad, Inc.
University of Michigan Rogel Cancer Center
Incyte Corporation
Memorial Sloan Kettering Cancer Center
Gritstone bio, Inc.
Incyte Corporation
Merck Sharp & Dohme LLC
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Bristol-Myers Squibb